https://www.selleckchem.com/products/ABT-888.html
002) while 4 (P = 0.01, 5 (P = 0.007) and 6 (P 0.001) mismatches had an increased risk of BOS. HLA-B mismatch was not associated with an increased mortality (P = 0.975) or BOS risk (P = 0.512). This study demonstrates a significant relationship between increased HLA mismatches and BOS development, with decreased overall survival only apparent with 6 mismatches. HLA-A and -DR mismatches were associated with an increased risk of mortality and BOS development compared to groups with at least 1 locus match. This study demonstrates a
إعجاب
علق
شارك
